Stocks-Prognosis.com
Search on StockPrognosis.com
To search on the site stockprognosis.com enter the name of the ticker, company name, or search phrase
Sections of the site



ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 28.9% Profit: QuantWave Success

May 16, 2023
ELI LILLY AND COMPANY stock has successfully reached the forecasted price target as predicted by QuantWave, yielding a significant profit of 28.9%. The forecast signal was initiated on February 8, 2023, when the stock was trading at 333.22 $. The forecast indicated a long position, and on May 16, 2023, the target price of 429.52 $ was realized.

This achievement underscores the accuracy and reliability of QuantWave's forecasting system, providing investors with valuable insights to make informed decisions in the market. The successful prediction for ELI LILLY AND COMPANY reflects the platform's ability to analyze market trends and identify profitable opportunities for its users.

In the broader context of QuantWave's analytics, this forecast success highlights the platform's potential for generating returns for investors. QuantWave offers a range of predictions for various stocks, allowing users to capitalize on market movements and optimize their investment strategies.

For investors seeking to enhance their understanding of QuantWave's forecasting methodology, QuantSchool offers a comprehensive educational resource. QuantSchool equips users with key principles for achieving consistent income through the QuantWave forecasting system, empowering them to make informed investment decisions and maximize their profit potential.
If you want to leave a comment, then you need Login or Register





Other data for LLY

Related data

LLYAugust 12, 2025Eli Lilly and Co LLY Traded Lower in Q2 Despite Good Results  ~1 min.

Eli Lilly and Company, despite reporting good results in the second quarter of this year, saw its stock price traded lower....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 20.09% Profit: QuantWave Achieves Success  ~1 min.

On January 28, 2025, QuantWave, an automated forecasting platform, issued a short signal for ELI LILLY AND COMPANY stock when it was trading at 800.2 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target, Generating 18.65% Profit for QuantWave Users  ~1 min.

ELI LILLY AND COMPANY's stock recently reached the price target forecasted by QuantWave on 2024-08-06. The forecast signal indicated a short position, with the stock priced at 786.06 $....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Short Price Target Forecast Resulting in 19.15% Profit for QuantWave Users  ~2 min.

ELI LILLY AND COMPANY (LLY) investors recently saw the stock hitting a short price target forecast set by QuantWave, resulting in a substantial profit of 19.15%....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Price Target Resulting in 19.55% Profit - QuantWave Success  ~1 min.

ELI LILLY AND COMPANY stock has successfully reached the price target as forecasted by QuantWave, resulting in a profitable 19.55% gain for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits QuantWave Forecast, Delivering 19.57% Profit  ~1 min.

ELI LILLY AND COMPANY has achieved the price target forecast set by QuantWave, signaling a 19.57% profit for investors....


LLYAugust 7, 2025ELI LILLY AND COMPANY Stock Hits Forecasted Price Target with 22.51% Profit  ~1 min.

ELI LILLY AND COMPANY stock recently achieved its forecasted price target as predicted by QuantWave, a leading automated forecasting platform....


LLYAugust 7, 2025ELI LILLY AND COMPANY Hits Forecast Price Target with 22.13% Profit on QuantWave Platform  ~2 min.

ELI LILLY AND COMPANY (LLY) recently achieved the forecast price target on the QuantWave platform, resulting in a remarkable 22.13% profit for investors who followed the short signal....


LLYAugust 1, 2025Eli Lilly and Company Completes Acquisition of Verve Therapeutics, Advancing One-Time Treatments for High Cardiovascular Risk  ~1 min.

Eli Lilly and Company has announced the successful completion of its acquisition of Verve Therapeutics, a move that will help advance innovative one-time treatments for individuals with high cardiovascular risk. This strategic decision showcases the company's commitment to revolutionizing the healthcare industry and improving patient outcomes. Investors are eagerly watching as Eli Lilly continues ...


LLYJuly 20, 2025Strong Q2 Forecast for ELI LILLY AND COMPANY by J.P. Morgan  ~1 min.

According to J.P. Morgan, Eli Lilly and Company is expected to have a strong second quarter performance. The pharmaceutical giant has been receiving positive attention from investors and analysts alike....


CRMDecember 18, 2023SALESFORCE, INC. Stock Hits QuantWave's Price Target Forecast with 22.2% Profit  ~1 min.

SALESFORCE, INC. (CRM) investors rejoiced as QuantWave's forecast signal successfully reached its price target, delivering a substantial 22.2% profit....


BACDecember 14, 2023Bank of America Stock Hits QuantWave’s Price Target with 19.49% Profit  ~1 min.

Bank of America Corporation's stock has successfully reached QuantWave's forecast price target, yielding a profitable return of 19.49%....


NISeptember 16, 2024QuantWave Successfully Hits Price Target for NiSource Inc., Generating 10.35% Profit  ~1 min.

QuantWave, the automated forecasting platform, has achieved yet another successful price target forecast, this time for NiSource Inc....


MAMarch 20, 2024QuantWave Forecast Accuracy: MASTERCARD INCORPORATED Price Target Hit, Generating 23.04% Profit  ~1 min.

On August 22, 2023, QuantWave's forecasting system indicated a long position for MASTERCARD INCORPORATED when the stock was trading at 393.77 $....


LLYMay 3, 2023ELI LILLY AND COMPANY Stock Hits Forecast Price Target with 18.45% Profit, Boosting Confidence in QuantWave's Analytics  ~2 min.

ELI LILLY AND COMPANY stock has successfully reached the price target forecasted by QuantWave, yielding a remarkable profit of 18.45%....